Life
New High-Throughput Platform for Covalent Protein Therapeutics Developed
Westlake University has introduced a high-throughput platform aimed at the efficient engineering of fast-acting covalent protein therapeutics, enhancing drug development processes.
Editorial Staff
1 min read
A research team at Westlake University, led by Bobo Dang and Ting Zhou, has created a high-throughput platform specifically designed for the engineering of covalent protein therapeutics.
This platform focuses on improving the efficiency of developing rapid-acting protein drugs, which could significantly impact therapeutic timelines and patient outcomes.
The implications of this technology extend to various applications in biotechnology, potentially streamlining processes in drug development and increasing throughput in therapeutic production.